Profile picture of Nikkei Asia
Japan's Shionogi eyes early 2025 for U.S. release of COVID pill: OSAKA -- Japanese drugmaker Shionogi expects to be able to sell its Xocova COVID-19 treatment in ...
asia.nikkei.com/Business/Pharmaceuticals/Japan-s-Shionogi-eyes-early-2025-for-U.S.-release-of-COVID-pill
Japan's Shionogi eyes early 2025 for U.S. release of COVID pill
Profile picture of Time
COVID-19 Antiviral Drugs Promise Speedier Recoveries. But They’re Not Available in the U.S.
time.com/6588624/covid-19-antiviral-treatments-us/
COVID-19 Antiviral Drugs Promise Speedier Recoveries. But They’re Not ...
Profile picture of The Atlantic
America May Be Missing Out on a Better COVID Treatment: A Japanese antiviral appears to shorten symptoms and protect against chronic disease. Also ...
theatlantic.com/health/archive/2023/10/xocova-ensitrelvir-covid-antiviral/675768/
America May Be Missing Out on a Better COVID Treatment
Profile picture of japannews.yomiuri.co.jp
Hokkaido Univ., Shionogi to Cooperate on Therapeutics to Protect Rare Birds from Avian Flu
japannews.yomiuri.co.jp/science-nature/science/20230724-124801/
Hokkaido Univ., Shionogi to Cooperate on Therapeutics to Protect Rare ...
Profile picture of Mainichi Shimbun
Shionogi seeks Taiwan approval for oral COVID-19 drug Xocova - The Mainichi: OSAKA (Kyodo) -- Shionogi & Co. said Tuesday it has applied to Taiwanese authorities ...
mainichi.jp/english/articles/20230411/p2g/00m/0sc/029000c
Shionogi seeks Taiwan approval for oral COVID-19 drug Xocova - The ...
Profile picture of Reuters
Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval: Japan's Shionogi & Co Ltd (4507.T) believes its COVID-19 pill will easily garner ...
reuters.com/business/healthcare-pharmaceuticals/shionogi-sees-covid-pill-reaping-2-billion-annual-sales-upon-us-approval-2023-02-27/
Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S ...
Profile picture of Mint (newspaper)
Finally, there's hope for long COVID treatment. Here's what it is | Mint: Ensitrelvir can shorten symptoms of mild to moderate COVID-19 by about a day
livemint.com/news/world/finally-there-s-hope-for-long-covid-treatment-here-s-what-it-is-11678192649508.html
Finally, there's hope for long COVID treatment. Here's what it is | Mint
Profile picture of Phys.org
Study finds evidence of resistance to COVID-19 drugs: Resistance to Paxlovid is already evident among viral SARS-CoV-2 variants currently circulating globally ...
medicalxpress.com/news/2023-03-evidence-resistance-covid-drugs.html
Study finds evidence of resistance to COVID-19 drugs
Profile picture of The Japan Times
Shionogi says its drug Xocova may reduce risks of long COVID symptoms: For 14 major symptoms of COVID-19, 14.5% of those given Xocova reported at least one of ...
japantimes.co.jp/news/2023/02/22/national/science-health/shionogi-drug-long-covid-reduce/
Shionogi says its drug Xocova may reduce risks of long COVID symptoms
Profile picture of Nikkei Asia
Shionogi seeks to break away from China for COVID drug materials: OSAKA -- Japanese drugmaker Shionogi will review how it sources raw materials for its oral ...
asia.nikkei.com/Business/Pharmaceuticals/Shionogi-seeks-to-break-away-from-China-for-COVID-drug-materials
Shionogi seeks to break away from China for COVID drug materials
Quick Glance: Ian Bremmer: Xi Jinping, China's modern-day emperor
  • Take in the most recent local, national, and international news.

  • As a result, Xi has an unrivaled ability to make arbitrary decisions that affect the lives of billions of people.

  • In terms of the economy, Xi's push for state control will result in decisions that are unchallenged by expert opinion and a surge in policy uncertainty.

  • There will be no "cultural revolution" or "great leap forward," and the size of China's educated urban middle class is one of the few checks on Xi's ability to implement such drastic measures.

  • However, maximum Xi has already cost China and the Chinese people a lot, and it will almost certainly cost them even more in 2023.
Profile picture of www3.nhk.or.jp
Japan distributes Xocova, first domestic COVID drug: Health authorities in Japan say the first locally-developed COVID drug, Xocova, can be used even by people ...
www3.nhk.or.jp/nhkworld/en/news/backstories/2156/
Japan distributes Xocova, first domestic COVID drug
Profile picture of Nikkei Asia
Japan's Shionogi seeks approval for COVID pill in South Korea: OSAKA -- Japanese drugmaker Shionogi said Wednesday that its COVID-19 pill has been submitted ...
asia.nikkei.com/Spotlight/Coronavirus/Japan-s-Shionogi-seeks-approval-for-COVID-pill-in-South-Korea
Japan's Shionogi seeks approval for COVID pill in South Korea
Profile picture of Nikkei Asia
Drugmaker Shionogi inks deal to market COVID pill in China: TOKYO -- Japanese drugmaker Shionogi announced a partnership with a Chinese counterpart on ...
asia.nikkei.com/Business/Pharmaceuticals/Drugmaker-Shionogi-inks-deal-to-market-COVID-pill-in-China
Drugmaker Shionogi inks deal to market COVID pill in China
Profile picture of japannews.yomiuri.co.jp

With integrated studies, teach children less to let them learn more
https://japannews.yomiuri.co.jp/society/general-news/20230107-82233/

Profile picture of The Japan Times
Shionogi applies for COVID-19 vaccine approval, would be first Japan-made: The recombinant protein-based preventive vaccine is the same type as a COVID-19 ...
japantimes.co.jp/news/2022/11/24/national/science-health/japan-shionogi-covid-vaccine/
Shionogi applies for COVID-19 vaccine approval, would be first Japan-made
Profile picture of The Japan Times
Shionogi COVID-19 pill Xocova wins emergency approval in Japan: A course of Shionogi’s treatment consists of seven pills over five days — significantly fewer ...
japantimes.co.jp/news/2022/11/22/national/science-health/shionogi-covid-xocova-approval/
Shionogi COVID-19 pill Xocova wins emergency approval in Japan
Profile picture of japannews.yomiuri.co.jp

Approval of Shionogi drug Xocova adds new weapon to Japan’s COVID-19 arsenal https://japannews.yomiuri.co.jp/society/coronavirus/20221123-72803/

Profile picture of Japan Today
Shionogi says Japanese gov't will buy 1 million more doses of COVID pill: Shionogi & Co Ltd said on Tuesday the Japanese government has agreed to ...
japantoday.com/category/national/shionogi-says-japan-government-to-buy-1-million-more-covid-pill-doses
Shionogi says Japanese gov't will buy 1 million more doses of COVID ...
Profile picture of The Asahi Shimbun
Shionogi seeks Japan approval for COVID-19 vaccine | The Asahi Shimbun: Breaking News, Japan News and Analysis
asahi.com/ajw/articles/14776886
Shionogi seeks Japan approval for COVID-19 vaccine | The Asahi Shimbun: ...
Profile picture of Mainichi Shimbun
Shionogi applies for COVID-19 vaccine approval, 1st as Japan-made - The Mainichi: OSAKA (Kyodo) -- Japanese pharmaceutical firm Shionogi & Co. said Thursday it ...
mainichi.jp/english/articles/20221124/p2g/00m/0sc/054000c
Shionogi applies for COVID-19 vaccine approval, 1st as Japan-made - The ...
Profile picture of The Japan Times
Shionogi says COVID-19 pill trial shows reduction in symptoms: The drug met the trial's goal of reducing five key symptoms of the omicron variant within 72 ...
japantimes.co.jp/news/2022/09/28/national/science-health/shionogi-covid19-drug-trial-results/
Shionogi says COVID-19 pill trial shows reduction in symptoms
Profile picture of Nikkei Asia
Japan's Shionogi says COVID pill reaches Phase 3 milestone: TOKYO (Reuters) -- Japan's Shionogi & Co. said on Wednesday its oral treatment for COVID-19 ...
asia.nikkei.com/Spotlight/Coronavirus/Japan-s-Shionogi-says-COVID-pill-reaches-Phase-3-milestone
Japan's Shionogi says COVID pill reaches Phase 3 milestone
Profile picture of Daily Maverick
COVID-19: Shionogi says Covid-19 pill trial shows reduction in symptoms: TOKYO, Sept 28 (Reuters) - Japan's Shionogi & Co Ltd 4507.T said on Wednesday its ...
dailymaverick.co.za/article/2022-10-03-shionogi-says-covid-19-pill-trial-shows-reduction-in-symptoms/
COVID-19: Shionogi says Covid-19 pill trial shows reduction in symptoms
Profile picture of Nikkei Asia
Japan's Shionogi seeks OK for COVID-19 pill in South Korea via tie-up: OSAKA -- Japanese drugmaker Shionogi will work with a company in South Korea to seek ...
asia.nikkei.com/Business/Pharmaceuticals/Japan-s-Shionogi-seeks-OK-for-COVID-19-pill-in-South-Korea-via-tie-up
Japan's Shionogi seeks OK for COVID-19 pill in South Korea via tie-up
Profile picture of Japan Today
Shionogi confirms efficacy of oral COVID drug for Omicron subvariant: Japanese pharmaceutical firm Shionogi & Co said Wednesday its oral COVID-19 drug ...
japantoday.com/category/national/shionogi-confirms-efficacy-of-oral-covid-drug-for-omicron-subvariant
Shionogi confirms efficacy of oral COVID drug for Omicron subvariant
Profile picture of japannews.yomiuri.co.jp

In deciding not to give emergency approval to a COVID-19 pill developed by Shionogi & Co., experts prioritized scientific corroboration over the need for ... Show more

Profile picture of Japan Today
Japan postpones decision to approve 1st domestic oral COVID-19 drug: A Japanese health ministry panel on Wednesday postponed a decision to approve the use of the ...
japantoday.com/category/national/update1-japan-postpones-decision-to-approve-1st-domestic-oral-covid-19-drug
Japan postpones decision to approve 1st domestic oral COVID-19 drug
Profile picture of The Star (Malaysia)
Shionogi Covid-19 pill fails to win Japan’s panel backing: Shionogi & Co’s experimental Covid-19 treatment Xocova failed to win the backing of health experts in ...
thestar.com.my/aseanplus/aseanplus-news/2022/07/20/shionogi-covid-19-pill-fails-to-win-japans-panel-backing
Shionogi Covid-19 pill fails to win Japan’s panel backing
Profile picture of The Japan Times
Japanese panel postpones verdict on Shionogi’s COVID pill until July: The panel “could not reach a conclusion,” as its members were divided over several points ...
japantimes.co.jp/news/2022/06/23/national/science-health/shionogi-covid19-pill-verdict-delay/
Japanese panel postpones verdict on Shionogi’s COVID pill until July
Profile picture of The Japan Times
As Japan's verdict on Shionogi's COVID pill nears, questions persist over efficacy
japantimes.co.jp/news/2022/06/21/national/shionogi-covid19-drug-panel-evaluation/
As Japan's verdict on Shionogi's COVID pill nears ...
Profile picture of Nikkei Asia
Shionogi to file as soon as June for COVID shot green light: TOKYO -- Japanese drugmaker Shionogi aims to seek as early as this month the government's ...
asia.nikkei.com/Spotlight/Coronavirus/COVID-vaccines/Shionogi-to-file-as-soon-as-June-for-COVID-shot-green-light
Shionogi to file as soon as June for COVID shot green light
Profile picture of The Asahi Shimbun

Shionogi says continuing Vietnam COVID projects after partner scandals
https://www.asahi.com/ajw/articles/14642105

Profile picture of CNA
Japan's Shionogi says COVID-19 pill shows rapid clearance of virus: TOKYO: An experimental treatment from Shionogi & Co has shown rapid clearance of the ...
channelnewsasia.com/asia/japans-shionogi-says-covid-19-pill-shows-rapid-clearance-virus-2644491
Japan's Shionogi says COVID-19 pill shows rapid clearance of virus
Profile picture of The Japan Times
Japanese firms turn to four-day week to improve work-life balance: Companies open to the arrangement are hoping staff will acquire new skills or develop a ...
japantimes.co.jp/news/2022/05/03/business/four-day-working-week-japan/
Japanese firms turn to four-day week to improve work-life balance
Profile picture of The Japan Times
U.S. in talks with Japan's Shionogi to buy new COVID-19 pill: Shionogi's treatment is in late-stage clinical trials and hasn’t yet been authorized ...
japantimes.co.jp/news/2022/04/22/business/corporate-business/shionogi-us-talks-covid-drug/
U.S. in talks with Japan's Shionogi to buy new COVID-19 pill
Profile picture of Nikkei Asia
Shionogi in talks with U.S. to supply COVID oral drug: OSAKA -- Japanese drugmaker Shionogi & Co. said Friday that it has entered talks with the U.S ...
asia.nikkei.com/Spotlight/Coronavirus/Shionogi-in-talks-with-U.S.-to-supply-COVID-oral-drug
Shionogi in talks with U.S. to supply COVID oral drug
Profile picture of Mainichi Shimbun
Shionogi to not recommend use of oral COVID drug for pregnant women - The Mainichi
mainichi.jp/english/articles/20220413/p2g/00m/0sc/008000c
Shionogi to not recommend use of oral COVID drug for pregnant women - The ...